氯霉素棕榈酸酯

更新时间:2024-01-03 12:07:30

氯霉素棕榈酸酯结构式
氯霉素棕榈酸酯结构式
品牌特惠专场
常用名 氯霉素棕榈酸酯 英文名 Chloramphenicol palmitate
CAS号 530-43-8 分子量 561.538
密度 1.2±0.1 g/cm3 沸点 691.6±55.0 °C at 760 mmHg
分子式 C27H42Cl2N2O6 熔点 90ºC
MSDS 中文版 美版 闪点 372.1±31.5 °C
符号 GHS08
GHS08
信号词 Warning

 氯霉素棕榈酸酯用途


【用途一】
抗菌素类药。

 氯霉素棕榈酸酯名称

中文名 氯霉素棕榈酸酯
英文名 chloramphenicol palmitate
中文别名 (2R,3R)-2-[(2,2-二氯乙酰基)氨基]-3-羟基-3-(4-硝基苯基)丙基棕榈酸酯 | 棕榈酸氯霉素酯
英文别名 更多

 氯霉素棕榈酸酯生物活性

描述 Chloramphenicol palmitate 是一种具有口服活性广谱抗生素 (antibiotic),对革兰氏阳性菌和革兰氏阴性菌有广泛的活性。Chloramphenicol palmitate 通过阻断肽基转移酶的合成来抑制细菌的蛋白质合成。Chloramphenicol palmitate 可作为含有氯霉素耐药基因的转化细胞的细菌筛选试剂 (bacterial selection agent)。
相关类别
参考文献

[1]. Siti Nani Nurbaeti, et al. Sustained-release Microparticle Dry Powders of Chloramphenicol Palmitate or Thiamphenicol Palmitate Prodrugs for Lung Delivery as Aerosols.Eur J Pharm Sci. 2019 Oct 1;138:105028.

 氯霉素棕榈酸酯物理化学性质

密度 1.2±0.1 g/cm3
沸点 691.6±55.0 °C at 760 mmHg
熔点 90ºC
分子式 C27H42Cl2N2O6
分子量 561.538
闪点 372.1±31.5 °C
精确质量 560.242004
PSA 121.45000
LogP 9.04
外观性状 晶体,溶于水
蒸汽压 0.0±2.3 mmHg at 25°C
折射率 1.526
储存条件 库房低温通风干燥

 氯霉素棕榈酸酯MSDS

 氯霉素棕榈酸酯毒性和生态

 氯霉素棕榈酸酯安全信息

符号 GHS08
GHS08
信号词 Warning
危害声明 H351
警示性声明 P280
个人防护装备 dust mask type N95 (US);Eyeshields;Gloves
危害码 (欧洲) Xn: Harmful;
风险声明 (欧洲) R40
安全声明 (欧洲) 36/37-36-26
危险品运输编码 NONH for all modes of transport
RTECS号 RT4735000
海关编码 29414000

 氯霉素棕榈酸酯合成线路

 氯霉素棕榈酸酯制备

【方法一】
将α-甲基吡啶及苯加入反应锅,搅拌下加入氯霉素,保持32-37℃,滴加棕榈酰氯。加毕,继续搅拌4h,加至15倍水中,析出粗品。粗品经洗涤、脱色、重结晶,即得无味氯霉素。

 氯霉素棕榈酸酯海关

海关编码 2924299090
中文概述 2924299090. 其他环酰胺(包括环氨基甲酸酯)(包括其衍生物以及他们的盐). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%
申报要素 品名, 成分含量, 用途, 包装
Summary 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 氯霉素棕榈酸酯文献22

更多文献
Structural, electronic, thermodynamical and charge transfer properties of Chloramphenicol Palmitate using vibrational spectroscopy and DFT calculations.

Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 101 , 335-42, (2013)

The global problem of advancing bacterial resistance to newer drugs has led to renewed interest in the use of Chloramphenicol Palmitate (C27H42Cl2N2O6) [Palmitic acid alpha ester with D-threo-(-),2-di...

Metabolism of some drugs by intestinal lactobacilli and their toxicological considerations.

Acta Pharmacol. Toxicol. (Copenh.) 58(1) , 11-5, (1986)

The bacterial metabolism of three drugs (sulphasalazine, phthalylsulphathiazole and chloramphenicol palmitate) and two dyes (tartrazine and methyl red) has been studied using a resting culture techniq...

The effect of exocrine pancreatic function on chloramphenicol pharmacokinetics in patients with cystic fibrosis.

Pediatr. Res. 23(4) , 388-92, (1988)

The effect of exocrine pancreatic function on the pharmacokinetics of the choramphenicol oral capsule (CAP-base), chloramphenicol palmitate oral liquid (CAP-P), and chloramphenicol succinate intraveno...

 氯霉素棕榈酸酯英文别名

Chlorambon
detreopal
CHLORAMPHENICOLPALMITATE,BP
cap-palmitate
Chloramphenicol palmitate
Clorolifarina
chloromycetinpalmitate
Hexadecanoic acid, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester
CHLORAMPHENICAL PALMITATE
(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate
D-threo-(-)-2,2-Dichloro-N-(β-hydroxy-α-(hydroxymethyl)-p-nitrophenethyl)acetamide α-palmitate
EINECS 208-477-9
MFCD00083597
CAP-P
Chloramphenicol palmitate (ester)
chloramphenicol 3'-palmitate
(2R,3R)-2-[(Dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl palmitate
[R-(R*,R*)]-Hexadecanoic Acid 2-[(Dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl Ester
Chloropal
D-threo-(-)-2,2-Dichloro-N-(b-hydroxy-a-(hydroxymethyl)-p-nitrophenethyl)acetamide a-Palmitate
chlorophenicol palmitate
品牌现货直购
推荐供应商:


查看所有供应商和价格请点击:

氯霉素棕榈酸酯生产厂家

氯霉素棕榈酸酯价格